Drugs / FlexHD
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT02372305 Comparator | Mar 2016 → Dec 2017 | breast neoplasm | University of Arkansas | Withdrawn | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | FlexHD | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02372305 ↗ |